Nanoparticle carrier co-delivery of complementary antibiofilm drugs abrogates dual species cariogenic biofilm formation in vitro

Detalhes bibliográficos
Autor(a) principal: Roncari Rocha, Guilherme [UNESP]
Data de Publicação: 2022
Outros Autores: Sims, Kenneth R., Xiao, Baixue, Klein, Marlise I. [UNESP], Benoit, Danielle S.W.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1080/20002297.2021.1997230
http://hdl.handle.net/11449/222948
Resumo: Background: Dental caries is a multifactorial disease caused by pathogenic biofilm. In particular, Streptococcus mutans synthesizes biofilm exopolysaccharides, while Candida albicans is associated with the development of severe carious lesions. Aim: This study aimed to prevent the formation of S. mutans and C. albicans biofilms by exploiting pH-sensitive nanoparticle carriers (NPCs) with high affinity to exopolysaccharides to increase the substantivity of multi-targeted antibiofilm drugs introduced topically in vitro. Methods: Dual-species biofilms were grown on saliva-coated hydroxyapatite discs with sucrose. Twice-daily, 1.5 min topical treatment regimens of unloaded and drug-loaded NPC were used. Drugs included combinations of two or three compounds with distinct, complementary antibiofilm targets: tt-farnesol (terpenoid; bacterial acid tolerance, fungal quorum sensing), myricetin (flavonoid; exopolysaccharides inhibitor), and 1771 (lipoteichoic acid inhibitor; bacterial adhesion and co-aggregation). Biofilms were evaluated for biomass, microbial population, and architecture. Results: NPC delivering tt-farnesol and 1771 with or without myricetin completely prevented biofilm formation by impeding biomass accumulation, bacterial and fungal population growth, and exopolysaccharide matrix deposition (vs. control unloaded NPC). Both formulations hindered acid production, maintaining the pH of spent media above the threshold for enamel demineralization. However, treatments had no effect on pre-established dual-species biofilms. Conclusion: Complementary antibiofilm drug-NPC treatments prevented biofilm formation by targeting critical virulence factors of acidogenicity and exopolysaccharides synthesis.
id UNSP_837a3b3570aa19c3186e0b7a3c20f362
oai_identifier_str oai:repositorio.unesp.br:11449/222948
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Nanoparticle carrier co-delivery of complementary antibiofilm drugs abrogates dual species cariogenic biofilm formation in vitroBiofilmCandida albicansdental cariesStreptococcus mutanstreatmentBackground: Dental caries is a multifactorial disease caused by pathogenic biofilm. In particular, Streptococcus mutans synthesizes biofilm exopolysaccharides, while Candida albicans is associated with the development of severe carious lesions. Aim: This study aimed to prevent the formation of S. mutans and C. albicans biofilms by exploiting pH-sensitive nanoparticle carriers (NPCs) with high affinity to exopolysaccharides to increase the substantivity of multi-targeted antibiofilm drugs introduced topically in vitro. Methods: Dual-species biofilms were grown on saliva-coated hydroxyapatite discs with sucrose. Twice-daily, 1.5 min topical treatment regimens of unloaded and drug-loaded NPC were used. Drugs included combinations of two or three compounds with distinct, complementary antibiofilm targets: tt-farnesol (terpenoid; bacterial acid tolerance, fungal quorum sensing), myricetin (flavonoid; exopolysaccharides inhibitor), and 1771 (lipoteichoic acid inhibitor; bacterial adhesion and co-aggregation). Biofilms were evaluated for biomass, microbial population, and architecture. Results: NPC delivering tt-farnesol and 1771 with or without myricetin completely prevented biofilm formation by impeding biomass accumulation, bacterial and fungal population growth, and exopolysaccharide matrix deposition (vs. control unloaded NPC). Both formulations hindered acid production, maintaining the pH of spent media above the threshold for enamel demineralization. However, treatments had no effect on pre-established dual-species biofilms. Conclusion: Complementary antibiofilm drug-NPC treatments prevented biofilm formation by targeting critical virulence factors of acidogenicity and exopolysaccharides synthesis.Department of Dental Materials and Prosthodontics São Paulo State UniversityDepartment of Biomedical Engineering University of RochesterMaterials Science Program University of RochesterDepartment of Orthopaedics and Center for Musculoskeletal Research University of RochesterCenter for Oral Biology University of RochesterDepartment of Chemical Engineering University of RochesterDepartment of Dental Materials and Prosthodontics São Paulo State UniversityUniversidade Estadual Paulista (UNESP)University of RochesterRoncari Rocha, Guilherme [UNESP]Sims, Kenneth R.Xiao, BaixueKlein, Marlise I. [UNESP]Benoit, Danielle S.W.2022-04-28T19:47:44Z2022-04-28T19:47:44Z2022-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1080/20002297.2021.1997230Journal of Oral Microbiology, v. 14, n. 1, 2022.2000-2297http://hdl.handle.net/11449/22294810.1080/20002297.2021.19972302-s2.0-85120174838Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengJournal of Oral Microbiologyinfo:eu-repo/semantics/openAccess2022-04-28T19:47:44Zoai:repositorio.unesp.br:11449/222948Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T21:53:23.305117Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Nanoparticle carrier co-delivery of complementary antibiofilm drugs abrogates dual species cariogenic biofilm formation in vitro
title Nanoparticle carrier co-delivery of complementary antibiofilm drugs abrogates dual species cariogenic biofilm formation in vitro
spellingShingle Nanoparticle carrier co-delivery of complementary antibiofilm drugs abrogates dual species cariogenic biofilm formation in vitro
Roncari Rocha, Guilherme [UNESP]
Biofilm
Candida albicans
dental caries
Streptococcus mutans
treatment
title_short Nanoparticle carrier co-delivery of complementary antibiofilm drugs abrogates dual species cariogenic biofilm formation in vitro
title_full Nanoparticle carrier co-delivery of complementary antibiofilm drugs abrogates dual species cariogenic biofilm formation in vitro
title_fullStr Nanoparticle carrier co-delivery of complementary antibiofilm drugs abrogates dual species cariogenic biofilm formation in vitro
title_full_unstemmed Nanoparticle carrier co-delivery of complementary antibiofilm drugs abrogates dual species cariogenic biofilm formation in vitro
title_sort Nanoparticle carrier co-delivery of complementary antibiofilm drugs abrogates dual species cariogenic biofilm formation in vitro
author Roncari Rocha, Guilherme [UNESP]
author_facet Roncari Rocha, Guilherme [UNESP]
Sims, Kenneth R.
Xiao, Baixue
Klein, Marlise I. [UNESP]
Benoit, Danielle S.W.
author_role author
author2 Sims, Kenneth R.
Xiao, Baixue
Klein, Marlise I. [UNESP]
Benoit, Danielle S.W.
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (UNESP)
University of Rochester
dc.contributor.author.fl_str_mv Roncari Rocha, Guilherme [UNESP]
Sims, Kenneth R.
Xiao, Baixue
Klein, Marlise I. [UNESP]
Benoit, Danielle S.W.
dc.subject.por.fl_str_mv Biofilm
Candida albicans
dental caries
Streptococcus mutans
treatment
topic Biofilm
Candida albicans
dental caries
Streptococcus mutans
treatment
description Background: Dental caries is a multifactorial disease caused by pathogenic biofilm. In particular, Streptococcus mutans synthesizes biofilm exopolysaccharides, while Candida albicans is associated with the development of severe carious lesions. Aim: This study aimed to prevent the formation of S. mutans and C. albicans biofilms by exploiting pH-sensitive nanoparticle carriers (NPCs) with high affinity to exopolysaccharides to increase the substantivity of multi-targeted antibiofilm drugs introduced topically in vitro. Methods: Dual-species biofilms were grown on saliva-coated hydroxyapatite discs with sucrose. Twice-daily, 1.5 min topical treatment regimens of unloaded and drug-loaded NPC were used. Drugs included combinations of two or three compounds with distinct, complementary antibiofilm targets: tt-farnesol (terpenoid; bacterial acid tolerance, fungal quorum sensing), myricetin (flavonoid; exopolysaccharides inhibitor), and 1771 (lipoteichoic acid inhibitor; bacterial adhesion and co-aggregation). Biofilms were evaluated for biomass, microbial population, and architecture. Results: NPC delivering tt-farnesol and 1771 with or without myricetin completely prevented biofilm formation by impeding biomass accumulation, bacterial and fungal population growth, and exopolysaccharide matrix deposition (vs. control unloaded NPC). Both formulations hindered acid production, maintaining the pH of spent media above the threshold for enamel demineralization. However, treatments had no effect on pre-established dual-species biofilms. Conclusion: Complementary antibiofilm drug-NPC treatments prevented biofilm formation by targeting critical virulence factors of acidogenicity and exopolysaccharides synthesis.
publishDate 2022
dc.date.none.fl_str_mv 2022-04-28T19:47:44Z
2022-04-28T19:47:44Z
2022-01-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1080/20002297.2021.1997230
Journal of Oral Microbiology, v. 14, n. 1, 2022.
2000-2297
http://hdl.handle.net/11449/222948
10.1080/20002297.2021.1997230
2-s2.0-85120174838
url http://dx.doi.org/10.1080/20002297.2021.1997230
http://hdl.handle.net/11449/222948
identifier_str_mv Journal of Oral Microbiology, v. 14, n. 1, 2022.
2000-2297
10.1080/20002297.2021.1997230
2-s2.0-85120174838
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Journal of Oral Microbiology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808129369860734976